Piramal Pharma Solutions Announces Integrated Development Program with Bolt Biotherapeutics for Immune-Stimulating Antibody Conjugates and Sterile Fill-Finish

    © 2024 Piramal Enterprises Ltd.

    Piramal Pharma Solutions Announces Acquisition of Solid Oral Dosage Drug Product Facility in Sellersville, Pennsylvania from G&W Laboratories Inc.

    Piramal Pharma Solutions Announces Collaboration with BerGenBio on the Development of FDA Fast Track Designated Leukemia Treatment

    Piramal Pharma Solutions Expands its High Potency API Capability at Riverview, MI Facility

    Piramal Pharma Solutions Transforms Chilkepally Mandal Parishad Primary School through its Community Engagement Programme

    Piramal Announces the Launch of Cinacalcet by its partner, Slate Run Pharmaceuticals, in the U.S.

    Piramal Pharma Solutions Unveils its New cGMP Kilo Lab Suite for Active Pharmaceutical Ingredient (API) at Ennore, Chennai

    Piramal Pharma Solutions Recognized as ‘Industry Partner of the Year’ at the Global Generics & Biosimilars Awards 2018.

    Piramal Pharma Solutions wins in six categories at the ‘CMO Leadership Awards 2018’

    Piramal Pharma Solutions wins ‘Industry Partner of the Year’ at the Global Generics & Biosimilars Awards 2017